2019 Sitaili Fou 3-Aminopyrazine-2-Carboxylic Acid CAS Nu. 5424-01-1

O le anoanoai o aafiaga tau pulega o galuega faatino ma na'o le tasi i le tasi le fa'ata'ita'iga fa'apitoa e faia ai le taua tele o feso'ota'iga fa'alapotopotoga ma lo matou malamalama faigofie i ou fa'amoemoega mo le 2019 New Style 3-Aminopyrazine-2-Carboxylic Acid CAS Nu. 5424-01-1, We o lo'o naunau e tu'uina atu ia te oe le tau sili ona maualalo i le maketi, sili ona lelei ma sili ona manaia fa'atau atu auaunaga.Welcome to do bussines with us,t's double win.
O le tele o aafiaga tau pulega o galuega faatino ma na'o le tasi i le tasi le fa'ata'ita'iga fa'apitoa e maua ai le taua tele o feso'ota'iga fa'alapotopotoga ma lo matou malamalama faigofie i ou fa'amoemoega moSaina 3-Aminopyrazine-2-Carboxylic Acid ma le 5424-01-1, O a tatou oloa e sili ona lauiloa i le upu, e pei o Amerika i Saute, Aferika, Asia ma isi.Kamupani e "fausia oloa muamua-vasega" e pei o le sini, ma taumafai e ofoina atu tagata faʻatau i ni fofo maualuga, tuʻuina atu tulaga maualuga pe a uma ona faʻatau atu auaunaga ma lagolago faʻapitoa, ma tagata faʻatau fefaʻatauaʻiga manuia, fatuina se galuega sili atu ma le lumanaʻi!

2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid o loʻo faʻaaogaina e avea ma mea vavalalata o Eltrombopag .
Eltrombopag, atiina ae e GlaxoSmithKline (GSK) i Peretania ma mulimuli ane atiina ae soofaatasi ma Novartis i Suitiselani, o le muamua ma e naʻo le faʻatagaina laiti mole non peptide TPO receptor agonist i le lalolagi.Eltrombopag na faʻamaonia e le US FDA i le 2008 mo le togafitiga o le idiopathic thrombocytopenic purpura (ITP), ma i le 2014 mo togafitiga o le maʻi aplastic anemia (AA).O le vailaʻau muamua foʻi na faʻamaonia e le US FDA mo togafitiga o le AA i le 30 tausaga talu ai nei.
I le december2012, ua faamaonia e le US FDA Eltrombopag mo le togafitiga o thrombocytopenia i tagata mamaʻi ma hepatitis C (CHC), ina ia hepatitis C maʻi ma le le lelei prognosis ona o le maualalo platelet faitau e mafai ona amata ma tausia interferon faavae togafitiga tulaga mo maʻi ate.I le Fepuari3, 2014, GlaxoSmithKline na faʻasalalau e le FDA na tuʻuina atu le agavaa o vailaʻau faʻapitoa mo togafitiga o Eltrombopag mo togafitiga o le hemopenia i tagata mamaʻi e maua i le chemicalbook aplastic anemia (SAA) e leʻi tali atoatoa i le immunotherapy.I le aso 24 o Aokuso, 2015, na faʻamaonia ai e le US FDA Eltrombopag mo togafitiga o le thrombocytopenia i tagata matutua ma tamaiti e taʻi 1 tausaga ma sili atu ma le thrombocytopenia puipuia tumau (ITP) e le lava le tali atu i corticosteroids, immunoglobulins poʻo splenectomy.I le Ianuari 4, 2018, na faʻamaonia ai Eltrombopag e lisiina i Saina mo togafitiga o le thrombocytopenia puipuia muamua (ITP).

O le anoanoai o aafiaga tau pulega o galuega faatino ma na'o le tasi i le tasi le fa'ata'ita'iga fa'apitoa e faia ai le taua tele o feso'ota'iga fa'alapotopotoga ma lo matou malamalama faigofie i ou fa'amoemoega mo le 2019 New Style 3-Aminopyrazine-2-Carboxylic Acid CAS Nu. 5424-01-1, We o lo'o naunau e tu'uina atu ia te oe le tau sili ona maualalo i le maketi, sili ona lelei ma sili ona manaia fa'atau atu auaunaga.Welcome to do bussines with us,t's double win.
2019 Sitaili FouSaina 3-Aminopyrazine-2-Carboxylic Acid ma le 5424-01-1, O a tatou oloa e sili ona lauiloa i le upu, e pei o Amerika i Saute, Aferika, Asia ma isi.Kamupani e "fausia oloa muamua-vasega" e pei o le sini, ma taumafai e ofoina atu tagata faʻatau i ni fofo maualuga, tuʻuina atu tulaga maualuga pe a uma ona faʻatau atu auaunaga ma lagolago faʻapitoa, ma tagata faʻatau fefaʻatauaʻiga manuia, fatuina se galuega sili atu ma le lumanaʻi!